M
Mohd. Aqil
Researcher at Jamia Hamdard
Publications - 188
Citations - 5549
Mohd. Aqil is an academic researcher from Jamia Hamdard. The author has contributed to research in topics: Transdermal & Chemistry. The author has an hindex of 33, co-authored 149 publications receiving 4252 citations. Previous affiliations of Mohd. Aqil include Hamdard University.
Papers
More filters
Journal ArticleDOI
Evaluation of Carbopol-Methyl Cellulose Based Sustained-Release Ocular Delivery System for Pefloxacin Mesylate Using Rabbit Eye Model
TL;DR: The results demonstrated that the carbopol/methyl cellulose mixture can be used as an in situ gelling vehicle to enhance the ocular bioavailability of pefloxacin mesylate.
Journal ArticleDOI
Development of clove oil based nanoemulsion of olmesartan for transdermal delivery: Box–Behnken design optimization and pharmacokinetic evaluation
TL;DR: A transdermal nanoemulsion formulation of olmesartan using Box-Behnken design and to evaluate it for pharmacokinetic study was developed and optimized in this paper, where the optimized formulation has presented the particle size of 53.11 ± 3.13 µm, polydispersity index 0.335 − 0.008 and transtermal flux 12.65 − 1.60 µm 2 /h.
Journal ArticleDOI
Part I: Development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin.
Mohd Abul Kalam,Mohd Abul Kalam,Yasmin Sultana,Asgar Ali,Mohd. Aqil,Anil K. Mishra,Ibrahim A. Aljuffali,Aws Alshamsan +7 more
TL;DR: This study aims to improve gatifloxacin bioavailability to the eye using solid-lipid nanoparticles (SLN) by optimizing formulations by three-factor, three-level Box-Behnken statistical design and in vitro release data were fitted to release kinetics equations.
Journal ArticleDOI
Design, formulation and optimization of valsartan transdermal gel containing iso-eucalyptol as novel permeation enhancer: preclinical assessment of pharmacokinetics in Wistar albino rats.
TL;DR: It was concluded that the developed transdermal gel accentuates the flux of valsartan and could be used as an antihypertensive dosage form for effectivetransdermal delivery of valartan.
Journal ArticleDOI
Ultrasonically tailored, chemically engineered and "QbD" enabled fabrication of agomelatine nanoemulsion; optimization, characterization, ex-vivo permeation and stability study.
TL;DR: The higher drug permeation profile of optimized Ago-NE confirmed that the solubility of agomelatine has been improved and was found to be 90% and 40% respectively.